Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of
infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an …

The newly emerged SARS-CoV-2 saltation variant, BA. 2.86, has raised global concern
(appendix 1 p 7). By Sept 8, 2023, 95 sequences were detected, of which their early …

The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused devastating impacts …

Since the outbreak of Severe Acute Respiratory Syndrome Virus-2 (SARS-CoV-2) in 2019,
more than 15 million spike protein sequences have been identified, raising a new challenge …

Introduction While there has been considerable progress in the development of vaccines
against SARS-CoV-2, largely based on the S (spike) protein of the virus, less progress has …

The ideal vaccine against viral infections should elicit antibody responses that protect
against divergent strains. Designing broadly protective vaccines against SARS-CoV-2 and …

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) impacted healthcare, the workforce, and worldwide socioeconomics. Multi …

Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a major global health concern associated with …

The SARS-CoV-2 virion has shown remarkable resilience, capable of mutating to escape
immune detection and re-establishing infectious capabilities despite new vaccine rollouts …